+86-17363028569        admin@mjn-cn.com
Home / News / Biological Role and Therapeutic Potential of IDH Mutations in Cancer

Biological Role and Therapeutic Potential of IDH Mutations in Cancer

Views: 1     Author: Site Editor     Publish Time: 2023-02-02      Origin: Site

Biological Role and Therapeutic Potential of IDH Mutations in Cancer


Hotspot mutations in isocitrate dehydrogenase 1 (IDH1) and isocitrate dehydrogenase 2 (IDH2) occur in a variety of myeloid malignancies and solid tumors. Mutant IDH proteins acquire a neomorphic enzyme activity to produce the putative oncometabolite D-2-hydroxyglutarate, which is thought to block cellular differentiation by competitively inhibiting α-ketoglutarate-dependent dioxygenases involved in histone and DNA demethylation. Small-molecule inhibitors of mutant IDH1 and IDH2 have been developed and are progressing through pre-clinical and clinical development. In this review, we provide an overview of mutant IDH-targeted therapy and discuss a number of important recent pre-clinical studies using models of IDH-mutant solid tumors.




Contact Mjn today to boost your
pharmaceutical business. 
We are ready to assist 24/7.

Quick Links

Product Category

Contact Us
  +86-17363028569        
  +86-19567906378
   No. 485, Zhonghua Street, Nanchang Street, Qiaoxi District, Shijiazhuang City
Copyright © 2023 Hebei Meijinnong Import and Export Trade Co., LTD. All rights reserved.